Seth M. Cohen

Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes.

Helical coordination polymers and cyclic dimers formed from heteroleptic thioether-dipyrrinato copper(II) complexes.

Potent, selective pyrone-based inhibitors of stromelysin-1.

Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.

Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.

Model complexes of cobalt-substituted matrix metalloproteinases: tools for inhibitor design.

Luminescent dipyrrinato complexes of trivalent group 13 metal ions.

Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins.

Discovery of an Inhibitor of the Proteasome Subunit Rpn11.

Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11.

Effect of donor atom identity on metal-binding pharmacophore coordination.

Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11.

Multicomponent metal-organic framework membranes for advanced functional composites.

Halogen bonding in UiO-66 frameworks promotes superior chemical warfare agent simulant degradation.

Block co-polyMOFs: morphology control of polymer-MOF hybrid materials.

Multiple functional groups in UiO-66 improve chemical warfare agent simulant degradation.

Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.

Room temperature aqueous synthesis of UiO-66 derivatives via postsynthetic exchange.

Probing the mechanisms of inhibition for various inhibitors of metallo-β-lactamases VIM-2 and NDM-1.

Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.

Effect of heterocycle content on metal binding isostere coordination.

Photorelease of a metal-binding pharmacophore from a Ru(II) polypyridine complex.

Correction: Photorelease of a metal-binding pharmacophore from a Ru(II) polypyridine complex.

F-Tagged metal binding pharmacophores for NMR screening of metalloenzymes.

Spectroscopic and biochemical characterization of metallo-β-lactamase IMP-1 with dicarboxylic, sulfonyl, and thiol inhibitors.

Mimicking the Electron Transport Chain and Active Site of [FeFe] Hydrogenases in One Metal-Organic Framework: Factors That Influence Charge Transport.

Free-standing metal-organic framework (MOF) monolayers by self-assembly of polymer-grafted nanoparticles.

Inside polyMOFs: layered structures in polymer-based metal-organic frameworks.

Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.

Correction: F-Tagged metal binding pharmacophores for NMR screening of metalloenzymes.

Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition.

Correction: Effect of heterocycle content on metal binding isostere coordination.

Electroactive Co(iii) salen metal complexes and the electrophoretic deposition of their porous organic polymers onto glassy carbon.

Correction: Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.

Self-healing mixed matrix membranes containing metal-organic frameworks.

Masking thiol reactivity with thioamide, thiourea, and thiocarbamate-based MBPs.

Enantioselective inhibition of the SARS-CoV-2 main protease with rhenium(i) picolinic acid complexes.

Correction: Masking thiol reactivity with thioamide, thiourea, and thiocarbamate-based MBPs.

Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5-Year Update.

Correction: Self-healing mixed matrix membranes containing metal-organic frameworks.

Erratum: Further correction: Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.

Catechol-O-Methyltransferase inhibition and alcohol use disorder: Evaluating the efficacy of tolcapone in ethanol-dependent rats.